Additionally, the relationship between KRTCAP2 expression and therapeutic response was examined using the CelIMiner Cross-Database and apoptosis assays.<h4>Results</h4>KRTCAP2 mRNA and protein levels were markedly upregulated in glioma tissues compared to non-tumorous brain tissues. The gene discussed is KRTCAP2; the disease is glioma.